According to our (Global Info Research) latest study, the global Continuous Glucose Monitoring (CGM) Technology market size was valued at US$ 10322 million in 2025 and is forecast to a readjusted size of US$ 25998 million by 2032 with a CAGR of 14.3% during review period.
Continuous Glucose Monitoring (CGM) Technology is a wearable biosensing approach that continuously measures glucose trends in body fluid and converts sensor signals into a stream of glucose estimates that can be viewed on a companion device or application. It typically combines a disposable sensor that interacts with glucose, miniature electronics that condition and transmit signals, and algorithms that filter noise, correct drift, and generate readings, trends, and alerts that support day-to-day glucose management without relying solely on intermittent fingerstick tests. The unit price typically ranges from tens to hundreds of dollars, with industry gross margins generally between 40% and 60%.
Upstream, the supply chain depends on specialized biosensor materials and processes, including enzyme chemistry, membranes, microfabricated electrodes, adhesives and biocompatible polymers, miniature electronics, wireless components, batteries, sterilization, and high-integrity packaging, with tight quality systems to control variability and calibration. Midstream, technology owners and device manufacturers integrate sensor production with firmware, mobile software, cloud services, cybersecurity, and regulatory compliance, while building scalable assembly, testing, and traceability across high-volume disposable components. Downstream, distribution flows through pharmacies, durable medical equipment channels, hospitals and clinics, and increasingly direct-to-consumer pathways, while demand is shaped by reimbursement policies, clinician prescribing behavior, training and support services, and interoperability with insulin pumps, smart pens, and digital health platforms that use CGM data for therapy adjustments and longer-term care management.
The Continuous Glucose Monitoring technology market is entering a scale phase where product leadership increasingly depends on end-to-end system performance rather than sensor accuracy alone. As adoption expands beyond intensive insulin users, winning platforms are those that minimize friction in everyday use, sustain reliable performance across varied lifestyles, and translate continuous readings into clear actions for patients and clinicians. The competitive battleground is shifting toward manufacturing yield, supply continuity, algorithm quality, and ecosystem integration with insulin delivery, clinical software, and pharmacy workflows. At the same time, the category is becoming more exposed to reimbursement discipline and consumer price sensitivity, which will push suppliers toward lower-cost designs, simplified onboarding, and broader channel strategies. Over the medium term, technology differentiation will come from longer wear, better signal stability, improved connectivity, and clinically credible software features that support decision making at scale, while regulatory expectations around safety, cybersecurity, and post-market surveillance will remain a defining barrier to entry.
This report is a detailed and comprehensive analysis for global Continuous Glucose Monitoring (CGM) Technology market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Continuous Glucose Monitoring (CGM) Technology market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Continuous Glucose Monitoring (CGM) Technology market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Continuous Glucose Monitoring (CGM) Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Continuous Glucose Monitoring (CGM) Technology market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Continuous Glucose Monitoring (CGM) Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Continuous Glucose Monitoring (CGM) Technology market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Medtronic, Dexcom, I-SENS, Senseonics, Sinocare, MicroTech Medical, POCTech, Meiqi Medical Equipment, Medtrum Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Continuous Glucose Monitoring (CGM) Technology market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Non-Invasive Monitoring
Invasive Monitoring
Market segment by Replacement Mechanism
Replaceable Type
Long-term Retention Type
Market segment by Intelligence
Basic Type
Intelligent Type
Market segment by Application
Hospital
Home Use
Others
Major players covered
Abbott
Medtronic
Dexcom
I-SENS
Senseonics
Sinocare
MicroTech Medical
POCTech
Meiqi Medical Equipment
Medtrum Technologies
SIBIONICS
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Continuous Glucose Monitoring (CGM) Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Continuous Glucose Monitoring (CGM) Technology, with price, sales quantity, revenue, and global market share of Continuous Glucose Monitoring (CGM) Technology from 2021 to 2026.
Chapter 3, the Continuous Glucose Monitoring (CGM) Technology competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Continuous Glucose Monitoring (CGM) Technology breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Continuous Glucose Monitoring (CGM) Technology market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Continuous Glucose Monitoring (CGM) Technology.
Chapter 14 and 15, to describe Continuous Glucose Monitoring (CGM) Technology sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Continuous Glucose Monitoring (CGM) Technology. Industry analysis & Market Report on Continuous Glucose Monitoring (CGM) Technology is a syndicated market report, published as Global Continuous Glucose Monitoring (CGM) Technology Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Continuous Glucose Monitoring (CGM) Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.